Skip to main content


Though we are disappointed we will not be together in-person, we remain dedicated to providing a first-class learning experience you’ve come to expect from HCCA.

This conference is a once-a-year opportunity to gain insight into properly monitoring, detecting, investigating, and managing violations. You will hear first-hand from government enforcement leaders about regulatory changes, expectations, and key priorities.  This year's speakers include representatives from the HHS-OIG, Civil Division of the DOJ, U.S. Department of Health and Human Services, Office of Counsel to the Inspector General as well as leaders in the healthcare enforcement compliance industry. View the full agenda

The 2020 Healthcare Enforcement Conference's educational sessions will provide you with the opportunity to earn live Compliance Certification Board (CCB)® continuing education units (CEUs). Learn more

Educational session topics:

  • False Claims Act
  • Cybersecurity and healthcare privacy
  • Fraud enforcement
  • Corporate integrity agreements 
  • Enforcement in clinical research
  • Privacy regulations
  • Managed care
  • Telehealth
  • CMS oversight
  • Anti-Kickback Statute
  • Stark Law
  • Compliance investigations
  • Opioid crisis

Who should attend?

  • Compliance officers
  • Chief quality officers
  • Presidents/CEOs
  • Senior internal auditors
  • Directors of compliance
  • Regulatory/risk officers
  • Government employees
  • General counsel
  • Compliance attorneys

Sponsoring
Interested in sponsoring with HCCA please view our prospectus.

New lower pricing is now available! 
Additional registration discounts apply for SCCE & HCCA members. Group discounts are also available. 

Attendees can purchase the conference session recording package for only $100.
Take advantage of this affordable opportunity to hear the sessions you may have missed and earn non-live CCB CEUs.

Pricing

Before 10/30/20

After 10/30/20

Members

$675

$725

Non – Members

$825

$875

Event Join Rate

$895

$945

Discounted Price for 3 or More – Member

$575

$625

Discounted Price for 3 or More – Non-Member

$725

$775

*Membership & Registration discount is only available for first time members who register for the event and membership at the same time.
**Discounts take effect the day a group reaches the discount number of registrants. Please send registration forms together to ensure that the discount is applied. 

General Session: Government Enforcement Panel
Kirk Ogrosky, Partner, Arnold & Porter
Gregory Demske, Chief Counsel to the Inspector General, HHS-OIG
Jamie Yavelberg, Deputy Director, Fraud Section, Commercial Litigation Branch, Civil Division DOJ

103: Preventing Enforcement Actions in Clinical Research - Operational Strategies for Avoiding Financial Frauds
Katherine Cohen, Chief Compliance Officer, Southern Illinois University Medicine
Sarah Couture, Managing Director, Ankura Consulting Group

General Session: CMS Update
Kim Brandt, Principal Deputy Administrator, CMS (Invited)

201: Managed Care Enforcement and Compliance
Benjamin Singer, Partner, O’Melveny & Myers LLP
Barbara Fonte, Vice President of Managed Care and Population Health, Jackson Health System
Sarah Kessler, Senior Counsel, HHS-OIG
Pamela Brecht, Attorney/Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP

303: Lessons Learned from Stark Law Investigations
David Glaser, Shareholder, Fredrikson & Byron PA
Matthew Krueger, United States Attorney, Eastern District of Wisconsin

403: Trends and Best Practices in Healthcare Privacy and Security Investigations
Timothy Noonan, Deputy Director, Health Information Privacy Division, U.S. Department of Health and Human Services Office for Civil Rights
Jonathan Skrmetti, Chief Deputy Attorney General, Office of Tennessee Attorney General
Brian Stimson, Principal Deputy General Counsel, U.S. Department of Health and Human Services

602: Civil and Criminal Telehealth Enforcement Matters; DME, Pharmaceutical and Other Covered Items and Services
Jason Mehta, Partner, Bradley Arant Boult Cummings
Colin Huntley, Assistant Director, Commercial Litigation Branch, Fraud Section, Civil Division, U.S. DOJ

General Session: DOJ’s Consumer Protection Branch: Safeguarding Americans from Dangerous Drugs and Devices
Gustav Eyler, Director, Consumer Protection Branch, U.S. Department of Justice

802: Enforcement and Compliance Risks Associated with the Opioid Crisis: Who's to Blame Will Cast a Wide Net
Colin Huntley, Assistant Director, Commercial Litigation Branch, Fraud Section, Civil Division, U.S. DOJ
Robert Trusiak, Compliance Officer, Catholic Charities Diocese of Rochester

901: CMS Oversight and Enforcement of Safety and Quality Standards
Peter Urbanowicz, Managing Director, Alvarez & Marsal
Mary Findley, Sr. Director, Alvarez & Marsal Healthcare Industry Group

903: Hot OIG Target Area: Device Reporting & Related Outlier Payments
Michael Calahan, V.P., Hospital & Physician Compliance , HealthCare Consulting Solutions

W1: Compliance, Internal Investigations and Self Disclosure: Building the Team, Process, and Resolution
Gabriel Imperato, Managing Partner, Nelson Mullins Riley & Scarborough
Nancy Hayt, VP Corporate Responsibility, Adventist Health System

W4: Negotiating and Mediating False Claims Act Cases
Sean O'Connell, Counsel, Hunton Andrews Kurth LLP
Janice Symchych, Mediator and Arbitrator, JAMS
Marc Raspanti, Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP
David Cohen, Senior Trial Counsel, U.S. Department of Justice

W7: Anatomy of a False Claims Act Case
Michael Morse, Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP
Lisa Re, Assistant Inspector General for Legal Affairs, Office of Inspector General, Department of Health & Human Services
Sean O'Connell, Counsel, Hunton Andrews Kurth LLP
Arthur Di Dio, Trial Attorney, US Department of Justice